| Document Date: 2014-02-05 08:39:26
Open Document File Size: 24,14 KBShare Result on Facebook
City Malaria Cambridge / / Company Cycad Group / Morningside Ventures / GlaxoSmithKline / Alexandria Real Estate Equities / Auriga Partners / Lux Capital Management / Staph Bakali Genocea Biosciences / Polaris Venture Partners / Genocea Biosciences / / Continent Asia / Africa / / Country United States / / Currency USD / / / Event Funding / Business Partnership / / IndustryTerm prevention of malaria / antigen discovery platform technology / / MedicalCondition sexually transmitted disease / pneumonia / extensive experience developing subunit malaria / headache / malaria / coma / and Malaria / fever / Malaria Malaria / serious infectious diseases / mosquito-transmitted illness / novel malaria / anemia / / Organization Congress / Naval Medical Research Center / U.S. Army Medical Research and Materiel Command / U.S. Military / / Person Leavenworth Bakali / Aline Schimmel / / / Position leader in novel vaccine development / president and chief executive officer / / ProvinceOrState Massachusetts / / PublishedMedium BusinessWeek / / Region sub-Saharan Africa / South Asia / / Technology T-cell-directed antigen discovery platform technology / / URL www.genocea.com / /
SocialTag |
Microsoft Word - GENOCEA CRADA malaria release FINAL